Intraportal human hepatocytes transplantation combined with placental mesenchymal stem cells and systemic intravenous placental mesenchymal stem cells infusion in decompensated liver cirrhosis
Denis Efimov, Belarus
Randomized phase 2 trial of felzartamab in humoral transplant rejection
Katharina Mayer, Austria
Spatial transcriptomics of kidney biopsies following adoptive regulatory T cell transfer reveals a marginal zone B cell signature and novel intra-graft immune interactions
Oliver McCallion, United Kingdom
Which immunodeficiency status has greater risks of poor pneumocystic pneumonia outcomes than other immunocompromised populations?
Poramed Winichakoon, Canada
Aire-Expressing Cells are Novel Mediators of Allograft Tolerance in a Murine Heterotopic Heart Transplant Model
Simon Chu, United States
Intragraft gene transcript changes with intravenous immunoglobulin therapy versus standard care in chronic antibody mediated rejection- vipar study cohort
Dhakshayini Tharmaraj, Australia
Spatial analysis of vascularised composite allografts reveals distinct transcriptional pathways and immune niche dynamics associated with rejection
Sarah Short, United Kingdom
Identification of patients with low likelihood of biopsy-proven acute rejection by donor-derived cell-free DNA and liver function tests in pediatric liver transplant
Guido Trezeguet Renatti, Argentina
Combination of SIRPa genotype in recipient and donor modulates immune response after living donor liver transplantation
Akhmet Seidakhmetov, Japan
Immunoisolation and islet survival in the absence of systemic immune suppression enabled by co-delivery of CXCL12 and FasL containing microgels in allo-islet transplanted diabetic mice
Fatma Dogan, United States
Combination therapy of low dose regulatory T cells and low dose IL-2 for transplant tolerance
Amy Cross, United Kingdom
Precision forecasting of eGFR in pediatric kidney transplant recipients using machine learning
Meraj Siddiqui, Turkey
Using spatial proteomics to explore the alloresponse in abdominal wall and small bowel biopsies
Helen Stark, United Kingdom
Males and females respond differently to 17beta-estradiol and methylprednisolone associated treatment during ex vivo lung perfusion of brain death rats
Marina Vidal dos Santos, Brazil
Unveiling the vital role of IL-2 and IL-5 in SARS-CoV-2 T-cell responses among kidney transplant recipients
Yvette den Hartog, The Netherlands
Desensitization-Resistant Eplet-Specific HLA Antibodies
Erol Demir, Turkey
Eliminating second warm ischemia in order to address the organ
shortage, increase transplant longevity, and enable minimally invasive
kidney transplantation: ex-vivo validation of a kidney anastomosis
facilitation and cooling device developed via the Biodesign process
Keith S. Hansen, United States
University of California, San Francisco
mTOR inhibitors promote highly functional T cell immunity in kidney transplant recipients vaccinated against COVID-19
Griffith B. Perkins, Australia
University of Adelaide, Athelstone
Real-life tacrolimus levels are associated with biopsy-proven acute rejection after the first year post-kidney transplantation
Soufian Meziyerh, The Netherlands
Leiden University Medical Center, Leiden
Investigating iron limitation in tolerance and regulatory T cells' dynamic iron requirements
Marie Sion, United Kingdom
University of Oxford, Oxford
Co-transplantation with adipose tissue-derived stem cells improves engraftment of transplanted hepatocytes
Hiroki Yamana, Japan
Tohoku University Hospital, Sendai
Every 2-month belatacept maintenance therapy in kidney transplant
recipients: 3-year follow-up of a randomized, non-inferiority trial
Aileen C. Johnson, United States
Emory Transplant Center, Atlanta, Georgia
Esmé Dijke, CanadaExpansion of Highly Suppressive FOXP3+ Regulatory T Cells from Pediatric Thymic Tissue |
Vivek Kute, IndiaNovel Strategy for Tolerance Induction in Living Donor Renal Transplantation |
Gisele Meinerz, BrazilIncreasing Incidence of Tuberculosis after Renal Transplantation in a Brazilian Center |
Miwa Morita, USALiver Stromal Cells Contribute to Liver Transplant Tolerance: Involved Cellular and Molecular Mechanisms |
Nicolas Poirier, FrancePreclinical Evaluation of FR104, An Antagonist Anti-CD28 Monovalent Fab’antibody, in DTH and Kidney Transplant Primates Models |
Thomas Rogerson, AustraliaTests for Latent Tuberculosis in Potential Transplant Recipients: A Systematic Review |
Moritz Schmelzle, USAIncreased Plasma Levels of CD133+ Microparticles Bearing Ectonucleotidases Are Noted in Acute Liver Failure in Patients and in Experimental Mouse Models |
Tina Schmidt, GermanyComparative Analysis of Assays for Detection of Cellular Immunity Towards CMV and M. Tuberculosis in Samples from Deceased Donors |
Adnan Sharif, United KingdomOne-Year Biopsy Data of Antibody-Incompatible Kidney Transplantation and Correlation with Medium-to-Long Term Risk of Allograft Loss – a Prospective Analysis |
Simo Syrjälä, FinlandAng1 Reduces Ischemia-Reperfusion Injury–Induced Microvascular Dysfunction and Chronic Rejection in |
Supported through an unrestricted educational grand from:
Cheguevara Afaneh, USADifferential regulation of positive or negative costimulatory molecules during acute rejection of human renal allografts |
Russell Hodgson, AustraliaProlonged xenograft survival induced by ICOS-IG Is associated with increased Foxp3+ cells |
Faisal Khan, CanadaGenomic instability after allogeneic hematopoietic cell transplantation is frequent in oral mucosa, particularly in patients with a history of chronic graft-vs-host disease, and rare in nasal mucosa |
Li Li, USAA highly specific novel 3 gene-set can non-invasively predict operational renal allograft tolerance |
Luiz Lisboa, CanadaIn vivo viral microRNA profiling in a large cohort of transplant patients with CMV disease |
Kate Markey, AustraliaGVHD-associated immune suppression is the result of an intrinsic defect in MHC class II antigen presentation within donor DC |
Susumu Shibasaki, JapanA single infusion of the ex-vivo generated immunoregulatory dendritic cells under a novel agent, NK026680 markedly prolongs cardiac allograft survival |
Kazuaki Tokodai, JapanInterruption of a cross-talk between the complement and coagulation cascades improves early outcomes after intraportal islet transplantation |
Hanna Trydzenskaya, GermanyNew protocol of BKV-specific T cell analysis allows for improved assessment of phenotypic and functional characteristics of BKV-specific immunity |
Laura Wozniak, USAValidation of a transcriptional profile of tolerance in pediatric liver transplant recipients |
Supported through an unrestricted educational grand from:
TTS • Genzyme Award
|
TTS • Genzyme Award
|
TTS • Novartis Award for Outstanding Investigator Driven Clinical TrialRutger Ploeg, The Netherlands |
TTS • Novartis Award
|
TTS • Roche Award
|
TTS • Roche Award
|
TTS • Roche Award
|
TTS • Roche Award
|
TTS • Roche Award
|
The Young Investigator Awards are given to recipients who have submitted abstracts to the International Congress of The Transplantation Society and received the highest scores from an international panel of reviewers. The award has been made possible by the generous support of Astellas Pharma Inc. since 1994. The recipients in 2006 during the 1st World Transplant Congress:
Ran TaoLIGATION OF BTLA ON EFFECTOR T CELLS BY HVEM EXPRESSED BY REGULATORY T CELLS (TREGS) CONTRAOLS THE SUPPRESSIVE FUNCTIONS OF TREGS IN VITRO AND IN VIVO |
Kerem H. BortecenLOCAL ADMINISTRATION OF IN VIVO GENERATED TREG PREVENT THE REJECTION OF ISLET ALLOGRAFTS |
Gang FengEX VIVO GENERATION OF REGULATORY T CELLS THAT PREVENT SKIN AND ISLET ALLOGRAFT REJECTION: A NOVEL ROLE FOR IFN-T. |
Kerem H. BortecenLOCAL ADMINISTRATION OF IN VIVO GENERATED TREG PREVENT THE REJECTION OF ISLET ALLOGRAFTS |
Martin BodingbauerPROPHYLACTIC BISPHOSPHONATE TREATMENT PREVENTS BONE FRACTURES AFTER LIVER TRANSPLANTATION |
Amy M. DowdenBONE MORPHOGENETIC PROTEIN 4 (BMP-4) PROMOTES IN VIVO DIFFERENTIATION OF EMBRYONIC STEM CELLS (ESC) INTO LYMPHOID AND MYELOID HEMATOPOIETIC CELLS |
Shin ItakuraMESENCHYMAL STEM CELLS FACILITATE INDUCTION OF MIXED CHIMERISM AND ISLET ALLOGRAFT TOLERANCE WITHOUT GVHD IN THE RAT |
Matthew J. VitaloneEPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) IN CHRONIC ALLOGRAFT NEPHROPATHY (CAN) |
Jose Caballero-CorbalanNO BENEFICIAL EFFECT OF THE TWO LAYER METHOD (PFC-UW) COMPARED WITH TRANSPORTATION IN UW ALONE ON THE OUTCOME OF HUMAN ISLET ISOLATION AND TRANSPLANTATION: A REPORT ON 214 HUMAN PANCREASES |
Iris LeeRETROVIRALLY-TRANSDUCED FOXP3+T CELLS PROMOTE PERMANENT SURVIVAL OF FULLY MHC-MISMATCHED CARDIAC ALLOGRAFTS IN IMMUNOCOMPETENT HOSTS |
Qiquan SunC4D-POSITIVE ACUTE REJECTION AT DIFFERENT TIME PERIODS AFTER RENAL TRANSPLANTATION: DIFFERENT CLINICO-HISTOPATHOLOGICAL MANIFESTATIONS REQUIRE DIFFERENT TREATMENT STRATEGIES |
Supported through an unrestricted educational grand from:
Koji Yazawa, BOSTON, MA , UNITED STATESNEITHER COMPLEMENT INHIBITION NOR DEPLETION OF NATURAL ANTIBODY IS REQUIRED TO AVOID HYPERACUTE OR ACCELERATED ACUTE REJECTION FOLLOW-ING GALT-KO PIG-TO-BABOON RENAL TRANSPLANTATION |
Tun Jie, MINNEAPOLIS, UNITED STATESPANCREATIC ISLET XENOTRANSPLANTS RESTORE NORMOGLYCEMIA AND INSULIN INDEPENDENCE IN IMMUNOSUPPRESSED NON-HUMAN PRIMATES |
Svjetlan Boskovic, BOSTON, MA, UNITED STATESLONG TERM (>5 YEARS) OBSERVATIONS IN RENAL ALLOGRAFT RECIPIENTS TREATED WITH CHIMERISM-INDUCING NONMYELOABLATIVE REGIMEN WITH CD154 BLOCKADE |
Michelle Solomon, LA JOLLA, UNITED STATESCONSTITUTIVE EXPRESSION OF SUPPRESSOR OF CYTOKINE SIGNALING-1 (SOCS-1) IN PANCREATIC ISLETS DELAYS ISLET ALLOGRAFT REJECTION |
Mona Doshi, IOWA CITY, IA, UNITED STATESSHORT AND LONG TERM OUTCOME OF LIVER TRANSPLANTS FROM DONORS DECEASED AFTER CARDIAC DEATH (DCD) |
Angela Webster, WESTMEAD, NSW, AUSTRALIAINCIDENCE, RISK AND PREDICTORS OF CANCER AFTER RENAL TRANSPLANTATION; ANANALYSIS OF ANZDATA, THE AUSTRALIA AND NEW ZEALAND DIALYSIS AND TRANSPLANT REGISTRY |
Maren Ruhnke, KIEL, GERMANYNORMALIZATION OF BLOOD GLUCOSE BY HUMAN MONOCYTE-DERIVED PANCREATIC ISLET-LIKE||CELLS IN STREPTOZOTOZIN DIABETIC MICE||-PERSPECTIVES FOR AUTOLOGOUS CELL THERAPY |
Hao Wang, LONDON, CANADAINHIBITION OF TERMINAL COMPLEMENT WITH A FUNCTIONALLY BLOCKING ANTI-C5 MONOCLONAL ANTIBODY PREVENTS ACUTE HUMORAL REJECTION AND ACCELERATED HUMORAL REJECTION IN A MOUSE CARDIAC ALLOGRAFT TRANSPLANTATION MODEL |
Constantino Fondevila, LOS ANGELES, UNITED STATESCYCLIC RGD PEPTIDES WITH HIGH AFFINITY FOR ALPHA5BETA1 INTEGRIN INHIBIT MACROPHAGE RECRUITMENT IN STEATOTIC LIVER ISCHEMIA/REPERFUSION INJURY |
Robert Öllinger, INNSBRUCK, AUSTRIABILIRUBIN SUPPRESSES NEOINTIMA FORMATION BY INTERACTING WITH THE RETINOBLASTOMA TUMOR SUPPRESSOR PROTEIN PATHWAY |
Cecile Braudeau, NANTES, FRANCEBLOOD CD25+CD4+ T CELLS PHENOTYPE AND REGULATION ASSOCIATED MOLECULES IN "OPERATIONALLY TOLERANT” VERSUS CHRONIC REJECTION HUMAN KIDNEY RECIPIENTS |
Supported through an unrestricted educational grand from:
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada